News summary

Clonal haematopoiesis of indeterminate potential and incident cardiovascular disease in individuals with MASLD

Source: Frontiers - Health • Published: 16 Nov 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

UK Biobank WES data found CHIP associates with increased CVD risk in MASLD.

Clonal haematopoiesis of indeterminate potential and incident cardiovascular disease in individuals with MASLD
Key Takeaways
  • CHIP was associated with increased cardiovascular events in MASLD.
  • CHIP and MASLD were reported to share inflammatory pathways.
  • Sequencing was found useful to identify higher-risk MASLD patients.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.